AU1440395A - Methods for the treatment or prevention of conditions associated with amyloidogenic reptides - Google Patents
Methods for the treatment or prevention of conditions associated with amyloidogenic reptidesInfo
- Publication number
- AU1440395A AU1440395A AU14403/95A AU1440395A AU1440395A AU 1440395 A AU1440395 A AU 1440395A AU 14403/95 A AU14403/95 A AU 14403/95A AU 1440395 A AU1440395 A AU 1440395A AU 1440395 A AU1440395 A AU 1440395A
- Authority
- AU
- Australia
- Prior art keywords
- reptides
- amyloidogenic
- prevention
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17154693A | 1993-12-21 | 1993-12-21 | |
US171546 | 1993-12-21 | ||
PCT/US1994/014655 WO1995017095A1 (en) | 1993-12-21 | 1994-12-14 | Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1440395A true AU1440395A (en) | 1995-07-10 |
Family
ID=22624148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14403/95A Abandoned AU1440395A (en) | 1993-12-21 | 1994-12-14 | Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0735821A4 (en) |
JP (1) | JPH09507071A (en) |
AU (1) | AU1440395A (en) |
CA (1) | CA2176127A1 (en) |
WO (1) | WO1995017095A1 (en) |
ZA (1) | ZA9410036B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL115582A0 (en) * | 1994-10-14 | 1996-01-19 | Lilly Co Eli | Methods for treating resistant tumors |
EP0895781A3 (en) * | 1994-10-20 | 1999-07-07 | Eli Lilly And Company | Use of benzofurans, benzothiophenes or indoles for the manufacture of a medicament for the treatment of conditions associated with an excess of tachykinins |
CA2206752A1 (en) * | 1996-07-02 | 1998-01-02 | George Joseph Cullinan | Benzothiophene compounds, intermediates, processes, and methods of use |
AU5585198A (en) * | 1996-11-22 | 1998-06-10 | Athena Pharmaceuticals, Inc. | N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and ethods for inhibiting beta-amyloid peptide release and/or its synthesis |
US5965614A (en) | 1996-11-22 | 1999-10-12 | Athena Neurosciences, Inc. | N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
AU7470098A (en) | 1997-04-30 | 1998-11-24 | Eli Lilly And Company | Antithrombotic agents |
JP2001522373A (en) | 1997-04-30 | 2001-11-13 | イーライ・リリー・アンド・カンパニー | Antithrombotic agent |
EP0973517A4 (en) | 1997-04-30 | 2002-07-24 | Lilly Co Eli | Antithrombotic agents |
US6350774B1 (en) | 1997-04-30 | 2002-02-26 | Eli Lilly And Company | Antithrombotic agents |
EP0988289A2 (en) | 1997-06-05 | 2000-03-29 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds, their production and use |
US5994396A (en) * | 1997-08-18 | 1999-11-30 | Centaur Pharmaceuticals, Inc. | Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
AU3171099A (en) * | 1998-04-17 | 1999-11-08 | Senga Pharmaceutical Laboratory Inc. | 1-heteroindene derivatives and medicinal composition containing the same |
US6284756B1 (en) | 1998-04-30 | 2001-09-04 | Eli Lilly And Company | Antithrombotic agents |
WO1999065309A1 (en) * | 1998-06-16 | 1999-12-23 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
AU751158B2 (en) | 1998-06-16 | 2002-08-08 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
US6288108B1 (en) | 1998-06-16 | 2001-09-11 | Eli Lilly And Company | Methods for increasing levels of acetylcholine |
ES2189355T3 (en) * | 1998-10-28 | 2003-07-01 | Lilly Co Eli | BENZOTIOPHENE COMPOUNDS AS ANTHROMBROTIC AND INTERMEDIATE AGENTS. |
JP2007526228A (en) * | 2003-06-23 | 2007-09-13 | ニューロケム (インターナショナル) リミテッド | Methods and compositions for the treatment of amyloid-related diseases and epilepsy-related diseases |
TW201018678A (en) | 2006-01-27 | 2010-05-16 | Astrazeneca Ab | Novel heteroaryl substituted benzothiazoles |
TW200813035A (en) | 2006-06-19 | 2008-03-16 | Astrazeneca Ab | Novel heteroaryl substituted benzoxazoles |
KR100858357B1 (en) * | 2006-10-02 | 2008-09-11 | (주) 디지탈바이오텍 | Composition comprising benzofuran type derivative for treating and preventing cognitive dysfunction |
JP2008231102A (en) * | 2007-02-23 | 2008-10-02 | Hiroaki Okuno | Phenol derivative having action for inhibiting amyloid beta aggregation |
TW200901998A (en) | 2007-03-06 | 2009-01-16 | Astrazeneca Ab | Novel 2-heteroaryl substituted benzothiophenes and benzofuranes |
US8193363B2 (en) | 2008-08-29 | 2012-06-05 | Astrazeneca Ab | Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024273A (en) * | 1974-06-20 | 1977-05-17 | Smithkline Corporation | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity |
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4230862A (en) * | 1975-10-28 | 1980-10-28 | Eli Lilly And Company | Antifertility compounds |
GB8704572D0 (en) * | 1987-02-26 | 1987-04-01 | Lundbeck & Co As H | Organic compounds |
US5185350A (en) * | 1991-09-23 | 1993-02-09 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
DE4311870C2 (en) * | 1993-04-10 | 1998-07-30 | Altramed Holdings Ltd | Use of an anti-oestrigen for the therapy and prophylaxis of dementia diseases |
EP0736007A4 (en) * | 1993-12-21 | 1997-03-19 | Lilly Co Eli | Non-peptide tachykinin receptor antagonists |
-
1994
- 1994-12-14 WO PCT/US1994/014655 patent/WO1995017095A1/en not_active Application Discontinuation
- 1994-12-14 EP EP95906018A patent/EP0735821A4/en not_active Withdrawn
- 1994-12-14 JP JP7517547A patent/JPH09507071A/en active Pending
- 1994-12-14 CA CA002176127A patent/CA2176127A1/en not_active Abandoned
- 1994-12-14 AU AU14403/95A patent/AU1440395A/en not_active Abandoned
- 1994-12-15 ZA ZA9410036A patent/ZA9410036B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995017095A1 (en) | 1995-06-29 |
CA2176127A1 (en) | 1995-06-29 |
EP0735821A4 (en) | 1998-04-01 |
JPH09507071A (en) | 1997-07-15 |
EP0735821A1 (en) | 1996-10-09 |
ZA9410036B (en) | 1996-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1440395A (en) | Methods for the treatment or prevention of conditions associated with amyloidogenic reptides | |
AU7545594A (en) | Implantable device for the treatment of aedemas | |
AU2103295A (en) | Methods for the treatment of thrombosis | |
AU5233493A (en) | Improving the biocompatibility of solid surfaces | |
AU5389194A (en) | Wastewater treatment | |
AU4032989A (en) | Method and compositions for the treatment and prevention of septic shock | |
AU1173195A (en) | Treatment of immunoregulatory disorders | |
AU6801694A (en) | The treatment of small animals | |
AU6232794A (en) | The use of nitric oxide-delivering compounds for the treatment or prevention of alcoholic liver injury | |
AU6946594A (en) | Methods for the treatment and prevention of diarrhea | |
AU6253094A (en) | Methods for the treatment of osteoporosis | |
AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
AU1278295A (en) | Wastewater treatment | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU4963793A (en) | Process of oxidation of bitumen or the like | |
EP0642337A1 (en) | Dapsone and promin for the treatment of dementia. | |
AU673961B2 (en) | Methods of inhibiting the effects of amyloidogenic proteins | |
AU3902393A (en) | Water treatment | |
AU1097892A (en) | Process and installation for the treatment of steel-mill slag | |
CY2375B1 (en) | Use of penciclorin for the treatment of post-therapeutic neuralgia. | |
AU6574894A (en) | Herbicidal treatment | |
AU6800994A (en) | Neuro-muscular stimulator | |
AU1587295A (en) | The treatment of gaseous substances | |
AU2671895A (en) | Bisquinolines for the treatment of malaria | |
AU1097995A (en) | Combination method for the treatment of patterned alopecia |